건강 상태

18 근거 기반 건강기능식품 연구가 있는 건강 상태

Explore health conditions with evidence-graded supplement recommendations. Each condition page ranks ingredients by the strength of clinical research supporting them.

How We Grade Evidence

각 건강 상태 페이지는 임상 근거의 강도에 따라 건강기능식품 성분의 순위를 매깁니다. 각 등급의 의미는 다음과 같습니다:

Strong Evidence

Multiple randomized controlled trials (RCTs) or meta-analyses with consistent positive results and large sample sizes.

Good Evidence

At least one RCT with mostly consistent results across studies. Evidence suggests benefit but more research may be needed.

Some Evidence

Small studies or observational data with some positive signals. Promising but insufficient for strong recommendations.

Very Early Research

In vitro studies, case reports, or pilot studies only. Early-stage research that requires clinical validation.

고혈압

47% of US adults (116 million); ~1.28 billion adults worldwide

Often asymptomatic ('silent killer') Severe: headache, shortness of breath, nosebleeds Chest pain +2

부정맥

Atrial fibrillation: 33.5 million worldwide; PVCs: present in 75% of healthy adults

Palpitations Skipped beats Racing heart +3

심부전

6.7 million US adults; prevalence increases with age (10% in adults >65)

Dyspnea (exertional and at rest) Orthopnea Paroxysmal nocturnal dyspnea +3

심계항진

Very common — up to 16% of primary care visits cite palpitations

Awareness of heartbeat Fluttering or pounding sensation Skipping beats +3

동맥경화증

Subclinical atherosclerosis present in >50% of adults over 40

Often asymptomatic until advanced Angina Claudication +1

고중성지방혈증

25-30% of US adults have elevated triglycerides (>=150 mg/dL)

Usually asymptomatic Very high levels (>500): eruptive xanthomas Lipemia retinalis +1

고호모시스테인혈증

5-10% of general population; up to 30-40% of elderly

Usually asymptomatic Associated with premature atherosclerosis Thromboembolism

대사증후군(심혈관 측면)

34% of US adults; prevalence increasing globally parallel to obesity epidemic

Central obesity (waist >40 inches men, >35 inches women) Elevated fasting glucose (>100 mg/dL) Elevated triglycerides (>150 mg/dL) +2

하지정맥류(만성 정맥부전)

20-30% of adults; higher in women (2:1 ratio)

Visible dilated veins Leg heaviness/aching Swelling (worse with standing) +3

혈액순환 저하

Symptoms of poor circulation affect 15-20% of adults >50

Cold hands/feet Numbness/tingling in extremities Slow wound healing +3

심근경색 후 회복

~805,000 MIs/year in the US; 200,000 are recurrent events

Fatigue Reduced exercise tolerance Chest discomfort +2

고지혈증(이상지질혈증)

38% of US adults have total cholesterol >=200 mg/dL; 12% have LDL >=160 mg/dL

Usually asymptomatic Xanthomas (tendon/skin deposits) in severe cases Corneal arcus +1

심혈관 염증

hs-CRP >2 mg/L present in ~25% of US adults

Usually measured by lab markers (hs-CRP, IL-6, TNF-alpha) Associated with accelerated atherosclerosis Plaque instability

산화 스트레스(심혈관)

Measurable biomarkers elevated in >80% of CVD patients

Subclinical; contributes to accelerated cardiovascular aging Associated with endothelial dysfunction Arterial stiffness +1

동맥 경직도 증가

Universal with aging; 20-30% of adults >60 have PWV >10 m/s

Usually asymptomatic Contributes to isolated systolic hypertension Widened pulse pressure +1

내피 기능 장애

Present in virtually all patients with cardiovascular risk factors

Usually asymptomatic (subclinical) Reduced exercise tolerance Erectile dysfunction +1

관상동맥질환(CAD)

20.5 million US adults; leading cause of death globally (17.9 million deaths/year)

Angina pectoris (chest pain/pressure with exertion) Shortness of breath Fatigue +1

말초동맥질환(PAD)

8.5 million US adults; 12-20% of adults >60 years

Intermittent claudication (leg pain with walking) Numbness/weakness in legs Cold legs/feet +2

FDA 면책 조항: 이 내용은 미국 식품의약국(FDA)의 평가를 받지 않았습니다. 이 웹사이트의 제품 및 정보는 질병의 진단, 치료, 완치 또는 예방을 목적으로 하지 않습니다. 제시된 근거 등급은 발표된 동료 심사 연구에 대한 우리의 분석에 기반하며, 의학적 조언을 구성하지 않습니다. 건강기능식품 복용을 시작하기 전에 반드시 의료 전문가와 상담하십시오.